Actinogen Medical Limited
ATGGF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $90,551 | $48,960 | $36,591 | $62,143 |
| - Cash | $16,504 | $9,451 | $8,460 | $16,370 |
| + Debt | $3,264 | $319 | $87 | $165 |
| Enterprise Value | $77,311 | $39,828 | $28,218 | $45,938 |
| Revenue | $5,490 | $9,932 | $4,888 | $3,640 |
| % Growth | -44.7% | 103.2% | 34.3% | – |
| Gross Profit | $5,490 | $9,932 | $4,482 | $3,239 |
| % Margin | 100% | 100% | 91.7% | 89% |
| EBITDA | -$15,013 | -$12,921 | -$15,218 | -$12,718 |
| % Margin | -273.5% | -130.1% | -311.3% | -349.4% |
| Net Income | -$14,732 | -$13,044 | -$10,752 | -$9,497 |
| % Margin | -268.4% | -131.3% | -220% | -260.9% |
| EPS Diluted | -0.005 | -0.006 | -0.006 | -0.005 |
| % Growth | 18.3% | -5.3% | -7.5% | – |
| Operating Cash Flow | -$7,556 | -$16,951 | -$8,698 | -$9,517 |
| Capital Expenditures | -$38 | -$8 | -$37 | -$3 |
| Free Cash Flow | -$7,594 | -$16,959 | -$8,735 | -$9,520 |